Binding of the hypoxia tracer [3h]misonidazole in cerebral ischemia

John M. Hoffman, Janet S. Rasey, Alexander M. Spence, Dennis W. Shaw, Kenneth A. Krohn

Research output: Contribution to journalArticlepeer-review

53 Scopus citations


Radiolabelled misonidazole, a radiosensitizing drug that binds to viable hypoxic tumor cells, may be useful in identifying hypoxic cells in cerebrovascular disease. Its potential was investigated in the gerbi l stroke model. Biodistribution of [3H] misonidazole was measured in normal gerbils and animals that had been subjected to right common carotid artery ligation to produce cerebral ischemia. The uptake of [3H]misonidazole in the right cerebral hemisphere and right/left hemispheral uptake ratios correlated positively with the severity of the stroke when measured 6-9 hours after carotid li gation. Histologic studies in symptomatic ligated animals showed ipsilateral widespread but patchy acute iscbemic changes as well as areas that showed no morphological changes. Microscopic autoradiography in these animals showed diffuse heavy labelling only in the ipsilateral hemisphere. This was over areas that had histological damage as well as in adjacent areas that appeared intact. Studies comparing blood flow measured with [C]iodoantipyrine and [3H] misonidazole retention in gerbils with carotid artery ligations indicated that flow is nota major determinant of retention of this hypoxia tracer. We conclude that a misonidazole congener labelled with a gamma- or positron-emitting isotope may be useful in nuclear imaging of the degree and regional distribution of hypoxic tissue in cerebrovascular disease.

Original languageEnglish (US)
Pages (from-to)168-116
Number of pages53
Issue number1
StatePublished - 1987
Externally publishedYes


  • Carotid ligation
  • Cerebrovascular disease
  • Gerbil stroke model
  • Nitroimidazole
  • Radiolabelled misonidazole

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing


Dive into the research topics of 'Binding of the hypoxia tracer [3h]misonidazole in cerebral ischemia'. Together they form a unique fingerprint.

Cite this